Biocon Biologics is well-placed to take advantage of opportunities in the biosimilars space: CEO Update Date： Post Date： CNBC Shreehas Tambe of Biocon Biologics discusses why he is optimistic about the prospects for the company. Tags CNBC Related Posts Harris Speaks Out On Why She Hasn’t Traveled To Southern BorderIsrael-Hamas war enters new phase as Israel expands offensive in GazaLegendary singer-songwriter Gordon Lightfoot dies at 84Texas cattle stampede away from plumes of smoke as wildfires force thousands to evacuate.Chicago Blackhawks GM Steps Down After Investigation Into 2010 Sexual Abuse18-month-old dies after being left in hot car after Fourth of July party Post navigation Nightly News Full Broadcast – Aug. 13S&P Global says oil prices are high right now because of summer demand
